I've been analyzing data from Remdesivir trial ov
Post# of 72440
(Total Views: 462)
Posted On: 04/29/2020 5:34:49 PM
I've been analyzing data from Remdesivir trial over and over again since this morning hype news.
This is negative trial IMO
Survival ( mortality) difference ( 8% vs 11.6%) is not statistically significant .
Duration of symptoms (11 vs 15 days) not statistically significance .
QoL data , including toxicity not revealed and we all know how Remdesivir can be toxic
I think this is failed study and sooner rather than later we will know the truth .
I think this news was released ( the preliminary results ) to give a false ( unfortunately) hopes, to quiet the market and for other less precise reasons.
It also tells us IPIX investors , how frantic and desperate gov's are to find the treatment.
Science is on our side and B will win big time!!!!!!
Stay all healthy and safe
aragon
This is negative trial IMO
Survival ( mortality) difference ( 8% vs 11.6%) is not statistically significant .
Duration of symptoms (11 vs 15 days) not statistically significance .
QoL data , including toxicity not revealed and we all know how Remdesivir can be toxic
I think this is failed study and sooner rather than later we will know the truth .
I think this news was released ( the preliminary results ) to give a false ( unfortunately) hopes, to quiet the market and for other less precise reasons.
It also tells us IPIX investors , how frantic and desperate gov's are to find the treatment.
Science is on our side and B will win big time!!!!!!
Stay all healthy and safe
aragon
(7)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼